fanta.bio Sample: CNhs11247
17400 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| HIF1A SRX11007095 | HK-2 Kidney | 2284 / 18754 (12.2%) | 1026 / 187540 (0.5%) | −324.0 | −324.0 | 22.26 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1769 / 18754 (9.4%) | 856 / 187540 (0.5%) | −324.0 | −324.0 | 20.67 |
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1071 / 18754 (5.7%) | 532 / 187540 (0.3%) | −324.0 | −324.0 | 20.13 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2489 / 18754 (13.3%) | 1297 / 187540 (0.7%) | −324.0 | −324.0 | 19.19 |
| SCML2 SRX644728 | 293 Kidney | 1546 / 18754 (8.2%) | 807 / 187540 (0.4%) | −324.0 | −324.0 | 19.16 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2407 / 18754 (12.8%) | 1276 / 187540 (0.7%) | −324.0 | −324.0 | 18.86 |
| HIF1A SRX20663235 | HK-2 Kidney | 524 / 18754 (2.8%) | 306 / 187540 (0.2%) | −324.0 | −324.0 | 17.12 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1548 / 18754 (8.3%) | 932 / 187540 (0.5%) | −324.0 | −324.0 | 16.61 |
| FOXP1 SRX736067 | LNCAP Prostate | 1906 / 18754 (10.2%) | 1260 / 187540 (0.7%) | −324.0 | −324.0 | 15.13 |
| MYH11 SRX265221 | ME-1 Blood | 863 / 18754 (4.6%) | 705 / 187540 (0.4%) | −324.0 | −324.0 | 12.24 |
| MED1 SRX9419945 | BT-474 Breast | 3360 / 18754 (17.9%) | 3273 / 187540 (1.7%) | −324.0 | −324.0 | 10.27 |
| BRD4 SRX9419935 | BT-474 Breast | 3323 / 18754 (17.7%) | 3282 / 187540 (1.8%) | −324.0 | −324.0 | 10.12 |
| MED1 SRX9419944 | BT-474 Breast | 3243 / 18754 (17.3%) | 3230 / 187540 (1.7%) | −324.0 | −324.0 | 10.04 |
| MED1 SRX9419946 | BT-474 Breast | 3377 / 18754 (18.0%) | 3443 / 187540 (1.8%) | −324.0 | −324.0 | 9.81 |
| BRD4 SRX9419937 | BT-474 Breast | 3271 / 18754 (17.4%) | 3347 / 187540 (1.8%) | −324.0 | −324.0 | 9.77 |
| BRD4 SRX9419938 | BT-474 Breast | 3335 / 18754 (17.8%) | 3451 / 187540 (1.8%) | −324.0 | −324.0 | 9.66 |
| BRD4 SRX9419936 | BT-474 Breast | 3338 / 18754 (17.8%) | 3455 / 187540 (1.8%) | −324.0 | −324.0 | 9.66 |
| MED1 SRX9419947 | BT-474 Breast | 3262 / 18754 (17.4%) | 3407 / 187540 (1.8%) | −324.0 | −324.0 | 9.57 |
| EZH2 SRX2146136 | LNCAP Prostate | 8021 / 18754 (42.8%) | 9041 / 187540 (4.8%) | −324.0 | −324.0 | 8.87 |
| BRD4 SRX736201 | 90-8TL Neural | 5825 / 18754 (31.1%) | 7501 / 187540 (4.0%) | −324.0 | −324.0 | 7.77 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1863 / 18754 (9.9%) | 2963 / 187540 (1.6%) | −324.0 | −324.0 | 6.29 |
| TP53 SRX19538279 | Osteoblasts Bone | 516 / 18754 (2.8%) | 318 / 187540 (0.2%) | −313.8 | −310.6 | 16.23 |
| TP53 SRX19538274 | U2OS Bone | 410 / 18754 (2.2%) | 195 / 187540 (0.1%) | −272.9 | −269.8 | 21.03 |
| TP53 SRX19538268 | U2OS Bone | 405 / 18754 (2.2%) | 199 / 187540 (0.1%) | −266.8 | −263.6 | 20.35 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 674 / 18754 (3.6%) | 1008 / 187540 (0.5%) | −256.9 | −253.8 | 6.69 |
| TP53 SRX19538276 | U2OS Bone | 405 / 18754 (2.2%) | 226 / 187540 (0.1%) | −255.4 | −252.2 | 17.92 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1338 / 18754 (7.1%) | 4146 / 187540 (2.2%) | −252.8 | −249.7 | 3.23 |
| TP53 SRX19538280 | Osteoblasts Bone | 403 / 18754 (2.1%) | 241 / 187540 (0.1%) | −247.7 | −244.6 | 16.72 |
| TP53 SRX19538267 | U2OS Bone | 366 / 18754 (2.0%) | 179 / 187540 (0.1%) | −241.4 | −238.4 | 20.45 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 390 / 18754 (2.1%) | 244 / 187540 (0.1%) | −235.6 | −232.6 | 15.98 |
| TP53 SRX19538273 | U2OS Bone | 358 / 18754 (1.9%) | 181 / 187540 (0.1%) | −233.6 | −230.5 | 19.78 |
| PBX4 SRX2731658 | PC-3 Prostate | 1401 / 18754 (7.5%) | 29481 / 187540 (15.7%) | −233.3 | −230.3 | 0.48 |
| TP53 SRX19538275 | U2OS Bone | 369 / 18754 (2.0%) | 210 / 187540 (0.1%) | −231.0 | −228.0 | 17.57 |
| TP53 SRX19538281 | Osteoblasts Bone | 422 / 18754 (2.3%) | 350 / 187540 (0.2%) | −226.1 | −223.1 | 12.06 |
| ESR1 SRX4367193 | MCF-7 Breast | 1206 / 18754 (6.4%) | 26400 / 187540 (14.1%) | −222.5 | −219.6 | 0.46 |
| ESR1 SRX7624157 | MCF-7 Breast | 974 / 18754 (5.2%) | 23021 / 187540 (12.3%) | −219.5 | −216.5 | 0.42 |
| ESR1 SRX20282961 | MCF-7 Breast | 475 / 18754 (2.5%) | 15197 / 187540 (8.1%) | −212.9 | −210.0 | 0.31 |
| ESR1 SRX176860 | MCF-7 Breast | 632 / 18754 (3.4%) | 17554 / 187540 (9.4%) | −208.7 | −205.7 | 0.36 |
| TP53 SRX19538269 | U2OS Bone | 453 / 18754 (2.4%) | 509 / 187540 (0.3%) | −207.2 | −204.3 | 8.90 |
| ESR1 SRX176861 | MCF-7 Breast | 634 / 18754 (3.4%) | 17517 / 187540 (9.3%) | −206.6 | −203.7 | 0.36 |
| ESR1 SRX7624156 | MCF-7 Breast | 622 / 18754 (3.3%) | 17302 / 187540 (9.2%) | −205.9 | −203.0 | 0.36 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 602 / 18754 (3.2%) | 1041 / 187540 (0.6%) | −205.5 | −202.6 | 5.78 |
| ESR1 SRX371469 | MCF-7 Breast | 408 / 18754 (2.2%) | 13771 / 187540 (7.3%) | −203.4 | −200.5 | 0.30 |
| AGO2 SRX4708039 | Hep G2 Liver | 1900 / 18754 (10.1%) | 8377 / 187540 (4.5%) | −203.1 | −200.2 | 2.27 |
| ESR1 SRX20282960 | MCF-7 Breast | 440 / 18754 (2.3%) | 14253 / 187540 (7.6%) | −201.7 | −198.9 | 0.31 |
| FOXA1 SRX176862 | MCF-7 Breast | 515 / 18754 (2.7%) | 15475 / 187540 (8.3%) | −201.7 | −198.9 | 0.33 |
| ESR1 SRX371478 | MCF-7 Breast | 519 / 18754 (2.8%) | 15416 / 187540 (8.2%) | −198.1 | −195.2 | 0.34 |
| FOXA1 SRX176863 | MCF-7 Breast | 478 / 18754 (2.5%) | 14754 / 187540 (7.9%) | −198.0 | −195.2 | 0.32 |
| IRF3 SRX11453858 | Hep G2 Liver | 278 / 18754 (1.5%) | 106 / 187540 (0.1%) | −197.7 | −194.9 | 26.23 |
| FOS SRX150477 | MCF 10A Breast | 956 / 18754 (5.1%) | 21934 / 187540 (11.7%) | −197.7 | −194.9 | 0.44 |
| ESR1 SRX1531791 | MCF-7 Breast | 384 / 18754 (2.0%) | 12999 / 187540 (6.9%) | −191.9 | −189.1 | 0.30 |
| FOS SRX150478 | MCF 10A Breast | 1014 / 18754 (5.4%) | 22484 / 187540 (12.0%) | −191.0 | −188.2 | 0.45 |
| ESR1 SRX20282939 | MCF-7 Breast | 462 / 18754 (2.5%) | 14255 / 187540 (7.6%) | −190.9 | −188.1 | 0.32 |
| TP53 SRX19538270 | U2OS Bone | 426 / 18754 (2.3%) | 501 / 187540 (0.3%) | −189.7 | −186.9 | 8.50 |
| FOXA1 SRX4815198 | MCF-7 Breast | 1351 / 18754 (7.2%) | 26964 / 187540 (14.4%) | −188.3 | −185.5 | 0.50 |
| ESR1 SRX20282972 | MCF-7 Breast | 455 / 18754 (2.4%) | 13958 / 187540 (7.4%) | −185.4 | −182.6 | 0.33 |
| FOXA1 SRX1161177 | MCF-7 Breast | 425 / 18754 (2.3%) | 13416 / 187540 (7.2%) | −183.9 | −181.1 | 0.32 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 585 / 18754 (3.1%) | 1126 / 187540 (0.6%) | −182.5 | −179.8 | 5.20 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 709 / 18754 (3.8%) | 17751 / 187540 (9.5%) | −181.8 | −179.0 | 0.40 |
| FOXA1 SRX371481 | MCF-7 Breast | 454 / 18754 (2.4%) | 13798 / 187540 (7.4%) | −181.3 | −178.5 | 0.33 |
| FOXA1 SRX1161176 | MCF-7 Breast | 401 / 18754 (2.1%) | 12921 / 187540 (6.9%) | −181.0 | −178.2 | 0.31 |
| FOXA1 SRX4815197 | MCF-7 Breast | 1011 / 18754 (5.4%) | 22041 / 187540 (11.8%) | −180.8 | −178.1 | 0.46 |
| GATA3 SRX190239 | MCF-7 Breast | 621 / 18754 (3.3%) | 16391 / 187540 (8.7%) | −180.7 | −177.9 | 0.38 |
| FOXA1 SRX371483 | MCF-7 Breast | 487 / 18754 (2.6%) | 14270 / 187540 (7.6%) | −179.5 | −176.8 | 0.34 |
| YAP1 SRX757325 | H2052 Lung | 1067 / 18754 (5.7%) | 22735 / 187540 (12.1%) | −178.9 | −176.2 | 0.47 |
| ESR1 SRX20282973 | MCF-7 Breast | 499 / 18754 (2.7%) | 14429 / 187540 (7.7%) | −178.6 | −175.9 | 0.35 |
| TP53 SRX19538282 | Osteoblasts Bone | 364 / 18754 (1.9%) | 362 / 187540 (0.2%) | −178.1 | −175.4 | 10.06 |
| ESR1 SRX20282954 | MCF-7 Breast | 461 / 18754 (2.5%) | 13755 / 187540 (7.3%) | −176.6 | −173.9 | 0.34 |
| ESR1 SRX194569 | MCF-7 Breast | 448 / 18754 (2.4%) | 13537 / 187540 (7.2%) | −176.3 | −173.6 | 0.33 |
| ESR1 SRX371479 | MCF-7 Breast | 404 / 18754 (2.2%) | 12815 / 187540 (6.8%) | −176.3 | −173.6 | 0.32 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 509 / 18754 (2.7%) | 14485 / 187540 (7.7%) | −175.8 | −173.1 | 0.35 |
| FOXA1 SRX1161173 | MCF-7 Breast | 340 / 18754 (1.8%) | 11718 / 187540 (6.2%) | −175.5 | −172.9 | 0.29 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 660 / 18754 (3.5%) | 1509 / 187540 (0.8%) | −175.4 | −172.7 | 4.37 |
| ESR1 SRX371467 | MCF-7 Breast | 451 / 18754 (2.4%) | 13551 / 187540 (7.2%) | −175.3 | −172.7 | 0.33 |
| BRD4 SRX736204 | 90-8TL Neural | 974 / 18754 (5.2%) | 3125 / 187540 (1.7%) | −174.0 | −171.3 | 3.12 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 506 / 18754 (2.7%) | 14374 / 187540 (7.7%) | −173.9 | −171.2 | 0.35 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 612 / 18754 (3.3%) | 15988 / 187540 (8.5%) | −173.3 | −170.7 | 0.38 |
| ESR1 SRX10365535 | MCF-7 Breast | 338 / 18754 (1.8%) | 11614 / 187540 (6.2%) | −173.3 | −170.7 | 0.29 |
| AR SRX10820653 | LNCAP Prostate | 313 / 18754 (1.7%) | 243 / 187540 (0.1%) | −172.9 | −170.3 | 12.88 |
| ESR1 SRX4367192 | MCF-7 Breast | 865 / 18754 (4.6%) | 19607 / 187540 (10.5%) | −171.2 | −168.6 | 0.44 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 948 / 18754 (5.1%) | 20765 / 187540 (11.1%) | −171.0 | −168.4 | 0.46 |
| ESR1 SRX20282955 | MCF-7 Breast | 449 / 18754 (2.4%) | 13362 / 187540 (7.1%) | −170.8 | −168.2 | 0.34 |
| ESR1 SRX194572 | MCF-7 Breast | 277 / 18754 (1.5%) | 10471 / 187540 (5.6%) | −170.7 | −168.1 | 0.26 |
| ESR1 SRX371476 | MCF-7 Breast | 328 / 18754 (1.7%) | 11349 / 187540 (6.1%) | −170.5 | −167.9 | 0.29 |
| IRF3 SRX11453861 | Hep G2 Liver | 246 / 18754 (1.3%) | 104 / 187540 (0.1%) | −169.9 | −167.3 | 23.65 |
| FOXA1 SRX1161175 | MCF-7 Breast | 330 / 18754 (1.8%) | 11317 / 187540 (6.0%) | −168.4 | −165.8 | 0.29 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 666 / 18754 (3.6%) | 1602 / 187540 (0.9%) | −167.9 | −165.4 | 4.16 |
| ESR1 SRX371468 | MCF-7 Breast | 286 / 18754 (1.5%) | 10541 / 187540 (5.6%) | −167.9 | −165.3 | 0.27 |
| TLE3 SRX4815191 | MCF-7 Breast | 432 / 18754 (2.3%) | 12973 / 187540 (6.9%) | −167.4 | −164.8 | 0.33 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 637 / 18754 (3.4%) | 16143 / 187540 (8.6%) | −167.4 | −164.8 | 0.39 |
| FOXA1 SRX371482 | MCF-7 Breast | 644 / 18754 (3.4%) | 16239 / 187540 (8.7%) | −167.1 | −164.5 | 0.40 |
| YAP1 SRX757326 | H2052 Lung | 930 / 18754 (5.0%) | 20328 / 187540 (10.8%) | −166.5 | −163.9 | 0.46 |
| 8-Hydroxydeoxyguanosine SRX6895232 | MCF 10A Breast | 980 / 18754 (5.2%) | 3257 / 187540 (1.7%) | −166.5 | −163.9 | 3.01 |
| FOXA1 SRX3931044 | MCF-7 Breast | 933 / 18754 (5.0%) | 20341 / 187540 (10.8%) | −165.8 | −163.2 | 0.46 |
| FOXA1 SRX1161174 | MCF-7 Breast | 452 / 18754 (2.4%) | 13232 / 187540 (7.1%) | −165.6 | −163.1 | 0.34 |
| ESR1 SRX371471 | ZR-75-1 Breast | 494 / 18754 (2.6%) | 13859 / 187540 (7.4%) | −164.6 | −162.1 | 0.36 |
| ESR1 SRX2881000 | MCF-7 Breast | 378 / 18754 (2.0%) | 11983 / 187540 (6.4%) | −164.2 | −161.7 | 0.32 |
| ESR1 SRX20282940 | MCF-7 Breast | 476 / 18754 (2.5%) | 13558 / 187540 (7.2%) | −164.1 | −161.5 | 0.35 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1392 / 18754 (7.4%) | 5848 / 187540 (3.1%) | −161.3 | −158.8 | 2.38 |
| GATA3 SRX176864 | MCF-7 Breast | 338 / 18754 (1.8%) | 11213 / 187540 (6.0%) | −161.1 | −158.6 | 0.30 |
| Epitope tags SRX10549776 | K-562 Blood | 1392 / 18754 (7.4%) | 5855 / 187540 (3.1%) | −160.9 | −158.4 | 2.38 |
| RAC1 SRX10365541 | MCF-7 Breast | 237 / 18754 (1.3%) | 9418 / 187540 (5.0%) | −160.1 | −157.6 | 0.25 |
| RAC1 SRX10365543 | MCF-7 Breast | 238 / 18754 (1.3%) | 9436 / 187540 (5.0%) | −160.0 | −157.5 | 0.25 |
| ESR1 SRX2881002 | MCF-7 Breast | 417 / 18754 (2.2%) | 12473 / 187540 (6.7%) | −159.9 | −157.4 | 0.33 |
| FOXA1 SRX11222437 | MCF-7 Breast | 322 / 18754 (1.7%) | 10890 / 187540 (5.8%) | −159.4 | −156.9 | 0.30 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 356 / 18754 (1.9%) | 11440 / 187540 (6.1%) | −158.8 | −156.3 | 0.31 |
| ESR1 SRX371470 | ZR-75-1 Breast | 428 / 18754 (2.3%) | 12605 / 187540 (6.7%) | −158.6 | −156.1 | 0.34 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 580 / 18754 (3.1%) | 14947 / 187540 (8.0%) | −158.2 | −155.7 | 0.39 |
| ESR1 SRX10365536 | MCF-7 Breast | 240 / 18754 (1.3%) | 9400 / 187540 (5.0%) | −157.7 | −155.2 | 0.26 |
| ESR1 SRX20282946 | MCF-7 Breast | 267 / 18754 (1.4%) | 9878 / 187540 (5.3%) | −157.7 | −155.2 | 0.27 |
| FOS SRX4192880 | MCF 10A Breast | 780 / 18754 (4.2%) | 17851 / 187540 (9.5%) | −157.5 | −155.0 | 0.44 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 421 / 18754 (2.2%) | 12450 / 187540 (6.6%) | −157.4 | −155.0 | 0.34 |
| 8-Hydroxydeoxyguanosine SRX2935292 | MCF 10A Breast | 1763 / 18754 (9.4%) | 8438 / 187540 (4.5%) | −156.8 | −154.4 | 2.09 |
| ESR1 SRX20282953 | MCF-7 Breast | 364 / 18754 (1.9%) | 11502 / 187540 (6.1%) | −156.8 | −154.4 | 0.32 |
| ESR1 SRX20282971 | MCF-7 Breast | 441 / 18754 (2.4%) | 12717 / 187540 (6.8%) | −156.0 | −153.5 | 0.35 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 454 / 18754 (2.4%) | 12891 / 187540 (6.9%) | −155.0 | −152.5 | 0.35 |
| TP53 SRX19538271 | U2OS Bone | 603 / 18754 (3.2%) | 1426 / 187540 (0.8%) | −154.7 | −152.2 | 4.23 |
| GATA3 SRX5057632 | MCF-7 Breast | 309 / 18754 (1.6%) | 10503 / 187540 (5.6%) | −154.5 | −152.1 | 0.29 |
| FOXA1 SRX371480 | MCF-7 Breast | 324 / 18754 (1.7%) | 10754 / 187540 (5.7%) | −154.3 | −151.9 | 0.30 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 357 / 18754 (1.9%) | 11283 / 187540 (6.0%) | −153.6 | −151.2 | 0.32 |
| FOS SRX150517 | MCF 10A Breast | 789 / 18754 (4.2%) | 17823 / 187540 (9.5%) | −153.6 | −151.2 | 0.44 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 432 / 18754 (2.3%) | 12492 / 187540 (6.7%) | −153.6 | −151.2 | 0.35 |
| ESR1 SRX371477 | MCF-7 Breast | 230 / 18754 (1.2%) | 9082 / 187540 (4.8%) | −153.3 | −150.9 | 0.25 |
| AR SRX10820651 | LNCAP Prostate | 330 / 18754 (1.8%) | 361 / 187540 (0.2%) | −153.3 | −150.8 | 9.14 |
| 8-Hydroxydeoxyguanosine SRX6895233 | MCF 10A Breast | 904 / 18754 (4.8%) | 3012 / 187540 (1.6%) | −152.8 | −150.4 | 3.00 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 909 / 18754 (4.8%) | 3067 / 187540 (1.6%) | −150.8 | −148.4 | 2.96 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 429 / 18754 (2.3%) | 12298 / 187540 (6.6%) | −149.4 | −147.0 | 0.35 |
| ESR1 SRX20282938 | MCF-7 Breast | 373 / 18754 (2.0%) | 11390 / 187540 (6.1%) | −149.1 | −146.7 | 0.33 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 244 / 18754 (1.3%) | 150 / 187540 (0.1%) | −148.5 | −146.1 | 16.27 |
| 8-Hydroxydeoxyguanosine SRX13840523 | MCF 10A Breast | 1860 / 18754 (9.9%) | 9340 / 187540 (5.0%) | −147.8 | −145.4 | 1.99 |
| BMI1 SRX644729 | 293 Kidney | 246 / 18754 (1.3%) | 158 / 187540 (0.1%) | −147.2 | −144.8 | 15.57 |
| ESR1 SRX330067 | MCF-7 Breast | 427 / 18754 (2.3%) | 12167 / 187540 (6.5%) | −146.7 | −144.3 | 0.35 |
| FOXA1 SRX3923514 | MCF-7 Breast | 484 / 18754 (2.6%) | 13059 / 187540 (7.0%) | −146.6 | −144.2 | 0.37 |
| FOXA1 SRX11222441 | MCF-7 Breast | 368 / 18754 (2.0%) | 11218 / 187540 (6.0%) | −146.5 | −144.1 | 0.33 |
| AGO2 SRX6783958 | Hep G2 Liver | 1204 / 18754 (6.4%) | 4919 / 187540 (2.6%) | −146.4 | −144.0 | 2.45 |
| ESR1 SRX5323871 | MCF-7 Breast | 509 / 18754 (2.7%) | 13429 / 187540 (7.2%) | −146.3 | −143.9 | 0.38 |
| 8-Hydroxydeoxyguanosine SRX13840522 | MCF 10A Breast | 1273 / 18754 (6.8%) | 5365 / 187540 (2.9%) | −146.2 | −143.8 | 2.37 |
| ESR1 SRX10365558 | MCF-7 Breast | 320 / 18754 (1.7%) | 10416 / 187540 (5.6%) | −146.2 | −143.8 | 0.31 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 1185 / 18754 (6.3%) | 22888 / 187540 (12.2%) | −145.5 | −143.2 | 0.52 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 999 / 18754 (5.3%) | 20390 / 187540 (10.9%) | −145.3 | −143.0 | 0.49 |
| ESR1 SRX330069 | MCF-7 Breast | 293 / 18754 (1.6%) | 9931 / 187540 (5.3%) | −145.3 | −142.9 | 0.30 |
| ESR1 SRX3110725 | MCF-7 Breast | 426 / 18754 (2.3%) | 12102 / 187540 (6.5%) | −145.2 | −142.8 | 0.35 |
| AGO2 SRX6783957 | Hep G2 Liver | 1218 / 18754 (6.5%) | 5031 / 187540 (2.7%) | −145.2 | −142.8 | 2.42 |
| FOXA2 SRX3230382 | Hep G2 Liver | 635 / 18754 (3.4%) | 15267 / 187540 (8.1%) | −145.1 | −142.7 | 0.42 |
| ESR1 SRX330070 | MCF-7 Breast | 247 / 18754 (1.3%) | 9127 / 187540 (4.9%) | −145.1 | −142.7 | 0.27 |
| RELA SRX2207673 | HUVEC Cardiovascular | 1610 / 18754 (8.6%) | 28313 / 187540 (15.1%) | −144.5 | −142.1 | 0.57 |
| NR2F2 SRX190293 | MCF-7 Breast | 501 / 18754 (2.7%) | 13239 / 187540 (7.1%) | −144.4 | −142.1 | 0.38 |
| ESR1 SRX8537722 | MCF-7 Breast | 440 / 18754 (2.3%) | 12286 / 187540 (6.6%) | −144.3 | −141.9 | 0.36 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 1338 / 18754 (7.1%) | 24817 / 187540 (13.2%) | −144.0 | −141.6 | 0.54 |
| JUNB SRX8488088 | SUM 229PE Breast | 906 / 18754 (4.8%) | 19050 / 187540 (10.2%) | −143.7 | −141.3 | 0.48 |
| AR SRX1067071 | LHSAR Prostate | 914 / 18754 (4.9%) | 19153 / 187540 (10.2%) | −143.5 | −141.2 | 0.48 |
| KAT7 SRX101303 | RKO Digestive tract | 1317 / 18754 (7.0%) | 5706 / 187540 (3.0%) | −143.4 | −141.1 | 2.31 |
| ESR1 SRX10365532 | MCF-7 Breast | 267 / 18754 (1.4%) | 9417 / 187540 (5.0%) | −143.3 | −141.0 | 0.28 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 1077 / 18754 (5.7%) | 21351 / 187540 (11.4%) | −143.3 | −141.0 | 0.50 |
| 8-Hydroxydeoxyguanosine SRX6895234 | MCF 10A Breast | 872 / 18754 (4.6%) | 2964 / 187540 (1.6%) | −143.0 | −140.7 | 2.94 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 484 / 18754 (2.6%) | 12923 / 187540 (6.9%) | −143.0 | −140.7 | 0.37 |
| ARID5B SRX3230377 | Hep G2 Liver | 1139 / 18754 (6.1%) | 22162 / 187540 (11.8%) | −142.9 | −140.6 | 0.51 |
| FOXA1 SRX11222442 | MCF-7 Breast | 325 / 18754 (1.7%) | 10382 / 187540 (5.5%) | −142.7 | −140.4 | 0.31 |
| ESR1 SRX2943591 | MCF-7 Breast | 346 / 18754 (1.8%) | 10726 / 187540 (5.7%) | −142.6 | −140.3 | 0.32 |
| FOXA1 SRX028634 | MCF-7 Breast | 244 / 18754 (1.3%) | 8992 / 187540 (4.8%) | −142.5 | −140.2 | 0.27 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 388 / 18754 (2.1%) | 11394 / 187540 (6.1%) | −142.3 | −140.0 | 0.34 |
| FOXA1 SRX100506 | Hep G2 Liver | 629 / 18754 (3.4%) | 15057 / 187540 (8.0%) | −142.0 | −139.7 | 0.42 |
| BRD1 SRX286203 | RKO Digestive tract | 1133 / 18754 (6.0%) | 4562 / 187540 (2.4%) | −141.3 | −139.0 | 2.48 |
| FOXA1 SRX1787653 | MCF-7 Breast | 405 / 18754 (2.2%) | 11614 / 187540 (6.2%) | −140.9 | −138.6 | 0.35 |
| CBX3 SRX055348 | HCT 116 Digestive tract | 385 / 18754 (2.1%) | 609 / 187540 (0.3%) | −140.6 | −138.3 | 6.32 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 1122 / 18754 (6.0%) | 21828 / 187540 (11.6%) | −140.5 | −138.2 | 0.51 |
| SSRP1 SRX3436567 | HT-1080 Bone | 392 / 18754 (2.1%) | 636 / 187540 (0.3%) | −140.4 | −138.2 | 6.16 |
| ESR1 SRX371475 | BT-474 Breast | 254 / 18754 (1.4%) | 9093 / 187540 (4.8%) | −140.3 | −138.0 | 0.28 |
| ESR1 SRX11120903 | MCF-7 Breast | 418 / 18754 (2.2%) | 11791 / 187540 (6.3%) | −140.0 | −137.8 | 0.35 |
| AR SRX9109110 | MDA-MB-453 Breast | 885 / 18754 (4.7%) | 18600 / 187540 (9.9%) | −139.9 | −137.6 | 0.48 |
| ESR1 SRX1469949 | MCF-7 Breast | 279 / 18754 (1.5%) | 9510 / 187540 (5.1%) | −139.7 | −137.4 | 0.29 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 537 / 18754 (2.9%) | 1255 / 187540 (0.7%) | −139.4 | −137.1 | 4.28 |
| FOXA1 SRX1787651 | MCF-7 Breast | 283 / 18754 (1.5%) | 9558 / 187540 (5.1%) | −139.2 | −136.9 | 0.30 |
| FOXA1 SRX3923516 | MCF-7 Breast | 352 / 18754 (1.9%) | 10703 / 187540 (5.7%) | −139.1 | −136.8 | 0.33 |
| FOXA1 SRX11222438 | MCF-7 Breast | 265 / 18754 (1.4%) | 9233 / 187540 (4.9%) | −138.7 | −136.4 | 0.29 |
| SMARCA2 SRX8119677 | MeT-5A Others | 785 / 18754 (4.2%) | 17151 / 187540 (9.1%) | −138.5 | −136.2 | 0.46 |
| FOXA1 SRX100477 | Hep G2 Liver | 545 / 18754 (2.9%) | 13676 / 187540 (7.3%) | −138.4 | −136.1 | 0.40 |
| ESR1 SRX1012629 | MCF-7 Breast | 310 / 18754 (1.7%) | 9984 / 187540 (5.3%) | −138.2 | −136.0 | 0.31 |
| ESR1 SRX5323873 | MCF-7 Breast | 592 / 18754 (3.2%) | 14371 / 187540 (7.7%) | −138.2 | −135.9 | 0.41 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 246 / 18754 (1.3%) | 8885 / 187540 (4.7%) | −138.1 | −135.8 | 0.28 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1743 / 18754 (9.3%) | 29652 / 187540 (15.8%) | −138.0 | −135.7 | 0.59 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 355 / 18754 (1.9%) | 10707 / 187540 (5.7%) | −137.8 | −135.6 | 0.33 |
| ESR1 SRX8537723 | MCF-7 Breast | 395 / 18754 (2.1%) | 11337 / 187540 (6.0%) | −137.5 | −135.2 | 0.35 |
| ESR1 SRX4451213 | MCF-7 Breast | 505 / 18754 (2.7%) | 13031 / 187540 (6.9%) | −137.1 | −134.9 | 0.39 |
| TLE3 SRX4815192 | MCF-7 Breast | 451 / 18754 (2.4%) | 12196 / 187540 (6.5%) | −137.0 | −134.7 | 0.37 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 459 / 18754 (2.4%) | 12307 / 187540 (6.6%) | −136.6 | −134.4 | 0.37 |
| EP300 SRX176885 | MCF-7 Breast | 264 / 18754 (1.4%) | 9115 / 187540 (4.9%) | −135.6 | −133.4 | 0.29 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 804 / 18754 (4.3%) | 2680 / 187540 (1.4%) | −135.5 | −133.3 | 3.00 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 780 / 18754 (4.2%) | 2547 / 187540 (1.4%) | −135.4 | −133.1 | 3.06 |
| FOXA2 SRX100448 | Hep G2 Liver | 543 / 18754 (2.9%) | 13528 / 187540 (7.2%) | −135.3 | −133.1 | 0.40 |
| ESR1 SRX2943589 | MCF-7 Breast | 260 / 18754 (1.4%) | 9034 / 187540 (4.8%) | −135.2 | −133.0 | 0.29 |
| LEO1 SRX1873456 | SEM Blood | 1454 / 18754 (7.8%) | 6797 / 187540 (3.6%) | −135.2 | −132.9 | 2.14 |
| 8-Hydroxydeoxyguanosine SRX13840520 | MCF 10A Breast | 898 / 18754 (4.8%) | 3232 / 187540 (1.7%) | −134.9 | −132.7 | 2.78 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 790 / 18754 (4.2%) | 17057 / 187540 (9.1%) | −134.6 | −132.4 | 0.46 |
| FOXA1 SRX028635 | MCF-7 Breast | 257 / 18754 (1.4%) | 8951 / 187540 (4.8%) | −134.2 | −132.0 | 0.29 |
| FOXA1 SRX5323843 | MCF-7 Breast | 268 / 18754 (1.4%) | 9135 / 187540 (4.9%) | −134.1 | −131.9 | 0.29 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 1120 / 18754 (6.0%) | 21506 / 187540 (11.5%) | −134.0 | −131.8 | 0.52 |
| ESR1 SRX1531796 | MCF-7 Breast | 272 / 18754 (1.5%) | 9191 / 187540 (4.9%) | −133.8 | −131.6 | 0.30 |
| ESR1 SRX2881001 | MCF-7 Breast | 273 / 18754 (1.5%) | 9209 / 187540 (4.9%) | −133.8 | −131.6 | 0.30 |
| ESR1 SRX3123829 | MCF-7 Breast | 293 / 18754 (1.6%) | 9531 / 187540 (5.1%) | −133.3 | −131.1 | 0.31 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 453 / 18754 (2.4%) | 12078 / 187540 (6.4%) | −133.0 | −130.8 | 0.38 |
| 8-Hydroxydeoxyguanosine SRX2935293 | MCF 10A Breast | 573 / 18754 (3.1%) | 1487 / 187540 (0.8%) | −132.9 | −130.6 | 3.85 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 757 / 18754 (4.0%) | 2457 / 187540 (1.3%) | −132.5 | −130.3 | 3.08 |
| BRPF3 SRX796086 | RKO Digestive tract | 1401 / 18754 (7.5%) | 6500 / 187540 (3.5%) | −132.3 | −130.1 | 2.16 |
| ESR1 SRX1469951 | MCF-7 Breast | 267 / 18754 (1.4%) | 9059 / 187540 (4.8%) | −132.3 | −130.1 | 0.29 |
| FOXA1 SRX1787655 | MCF-7 Breast | 261 / 18754 (1.4%) | 8952 / 187540 (4.8%) | −132.2 | −130.0 | 0.29 |
| ARID1A SRX5089376 | MCF-7 Breast | 450 / 18754 (2.4%) | 12001 / 187540 (6.4%) | −132.0 | −129.8 | 0.37 |
| FOXA1 SRX3923517 | MCF-7 Breast | 362 / 18754 (1.9%) | 10615 / 187540 (5.7%) | −132.0 | −129.8 | 0.34 |
| FOXA1 SRX5203303 | MCF-7 Breast | 177 / 18754 (0.9%) | 7441 / 187540 (4.0%) | −131.8 | −129.6 | 0.24 |
| ESR1 SRX5323877 | MCF-7 Breast | 392 / 18754 (2.1%) | 11073 / 187540 (5.9%) | −131.4 | −129.2 | 0.35 |
| CDK9 SRX7366783 | MCF-7 Breast | 233 / 18754 (1.2%) | 173 / 187540 (0.1%) | −131.4 | −129.2 | 13.47 |
| ESR1 SRX5323872 | MCF-7 Breast | 501 / 18754 (2.7%) | 12749 / 187540 (6.8%) | −131.3 | −129.1 | 0.39 |
| CEBPA SRX2630241 | Hep G2 Liver | 609 / 18754 (3.2%) | 14340 / 187540 (7.6%) | −131.1 | −128.9 | 0.42 |
| AR SRX1067070 | LHSAR Prostate | 1155 / 18754 (6.2%) | 21831 / 187540 (11.6%) | −131.1 | −128.9 | 0.53 |
| Epitope tags SRX5877912 | U2OS Bone | 2521 / 18754 (13.4%) | 38642 / 187540 (20.6%) | −131.0 | −128.8 | 0.65 |
| ARID1A SRX5089379 | MCF-7 Breast | 502 / 18754 (2.7%) | 12750 / 187540 (6.8%) | −130.9 | −128.7 | 0.39 |
| GATA3 SRX6712581 | MCF-7 Breast | 420 / 18754 (2.2%) | 11491 / 187540 (6.1%) | −130.9 | −128.7 | 0.37 |
| ESR1 SRX2513517 | MCF-7 Breast | 346 / 18754 (1.8%) | 10316 / 187540 (5.5%) | −130.8 | −128.6 | 0.34 |
| ESR1 SRX20282959 | MCF-7 Breast | 217 / 18754 (1.2%) | 8128 / 187540 (4.3%) | −130.5 | −128.3 | 0.27 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 481 / 18754 (2.6%) | 12412 / 187540 (6.6%) | −130.4 | −128.2 | 0.39 |
| CEBPB SRX190345 | MCF-7 Breast | 393 / 18754 (2.1%) | 11052 / 187540 (5.9%) | −130.4 | −128.2 | 0.36 |
| ESR1 SRX371474 | BT-474 Breast | 248 / 18754 (1.3%) | 8668 / 187540 (4.6%) | −130.3 | −128.2 | 0.29 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 548 / 18754 (2.9%) | 13413 / 187540 (7.2%) | −130.3 | −128.1 | 0.41 |
| FOXA1 SRX3923518 | MCF-7 Breast | 356 / 18754 (1.9%) | 10462 / 187540 (5.6%) | −130.3 | −128.1 | 0.34 |
| FOXA1 SRX1447316 | MCF-7 Breast | 216 / 18754 (1.2%) | 8098 / 187540 (4.3%) | −130.2 | −128.0 | 0.27 |
| ESR1 SRX1012632 | MCF-7 Breast | 259 / 18754 (1.4%) | 8846 / 187540 (4.7%) | −130.1 | −127.9 | 0.29 |
| FOXA1 SRX3931043 | MCF-7 Breast | 519 / 18754 (2.8%) | 12972 / 187540 (6.9%) | −130.0 | −127.9 | 0.40 |
| FOS SRX150476 | MCF 10A Breast | 868 / 18754 (4.6%) | 17937 / 187540 (9.6%) | −129.9 | −127.7 | 0.48 |
| BRPF3 SRX796084 | RKO Digestive tract | 1438 / 18754 (7.7%) | 6816 / 187540 (3.6%) | −129.6 | −127.4 | 2.11 |
| PROX1 SRX3230397 | Hep G2 Liver | 370 / 18754 (2.0%) | 10659 / 187540 (5.7%) | −129.5 | −127.4 | 0.35 |
| BRPF3 SRX796085 | RKO Digestive tract | 1014 / 18754 (5.4%) | 4026 / 187540 (2.1%) | −129.2 | −127.1 | 2.52 |
| AR SRX9469988 | LAPC-4 Prostate | 665 / 18754 (3.5%) | 15067 / 187540 (8.0%) | −129.1 | −127.0 | 0.44 |
| FOXA1 SRX3931054 | MCF-7 Breast | 484 / 18754 (2.6%) | 12400 / 187540 (6.6%) | −128.9 | −126.8 | 0.39 |
| ESR1 SRX2513520 | MCF-7 Breast | 325 / 18754 (1.7%) | 9908 / 187540 (5.3%) | −128.8 | −126.6 | 0.33 |
| SS18 SRX3468047 | Fibroblasts Others | 1202 / 18754 (6.4%) | 22336 / 187540 (11.9%) | −128.8 | −126.6 | 0.54 |
| ESR1 SRX2912055 | MCF-7 Breast | 205 / 18754 (1.1%) | 7859 / 187540 (4.2%) | −128.7 | −126.6 | 0.26 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 403 / 18754 (2.1%) | 755 / 187540 (0.4%) | −128.6 | −126.5 | 5.34 |
| YAP1 SRX5718140 | 293 Kidney | 843 / 18754 (4.5%) | 17537 / 187540 (9.4%) | −128.5 | −126.4 | 0.48 |
| ESR1 SRX330068 | MCF-7 Breast | 255 / 18754 (1.4%) | 8721 / 187540 (4.7%) | −128.4 | −126.3 | 0.29 |
| FOXA1 SRX100454 | T-47D Breast | 662 / 18754 (3.5%) | 14993 / 187540 (8.0%) | −128.3 | −126.2 | 0.44 |
| FOXA1 SRX3923515 | MCF-7 Breast | 291 / 18754 (1.6%) | 9328 / 187540 (5.0%) | −128.3 | −126.1 | 0.31 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 1568 / 18754 (8.4%) | 26965 / 187540 (14.4%) | −128.1 | −126.0 | 0.58 |
| STAT5B SRX831881 | CD8+ T cells Blood | 230 / 18754 (1.2%) | 176 / 187540 (0.1%) | −128.0 | −125.9 | 13.07 |
| EP300 SRX2194266 | SUM 159PT Breast | 849 / 18754 (4.5%) | 17589 / 187540 (9.4%) | −127.9 | −125.7 | 0.48 |
| ESR1 SRX5323878 | MCF-7 Breast | 506 / 18754 (2.7%) | 12691 / 187540 (6.8%) | −127.9 | −125.7 | 0.40 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 446 / 18754 (2.4%) | 11780 / 187540 (6.3%) | −127.8 | −125.7 | 0.38 |
| TEAD1 SRX3401272 | MCF-7 Breast | 396 / 18754 (2.1%) | 11002 / 187540 (5.9%) | −127.7 | −125.6 | 0.36 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 266 / 18754 (1.4%) | 8882 / 187540 (4.7%) | −127.6 | −125.5 | 0.30 |
| FOXA1 SRX3931055 | MCF-7 Breast | 441 / 18754 (2.4%) | 11686 / 187540 (6.2%) | −127.4 | −125.3 | 0.38 |
| CEBPB SRX150632 | HeLa Uterus | 1095 / 18754 (5.8%) | 20856 / 187540 (11.1%) | −127.0 | −124.9 | 0.53 |
| SOX13 SRX2636248 | Hep G2 Liver | 689 / 18754 (3.7%) | 15319 / 187540 (8.2%) | −126.9 | −124.8 | 0.45 |
| ESR1 SRX10365533 | MCF-7 Breast | 257 / 18754 (1.4%) | 8691 / 187540 (4.6%) | −126.4 | −124.2 | 0.30 |
| HMG20A SRX2630163 | Hep G2 Liver | 296 / 18754 (1.6%) | 9325 / 187540 (5.0%) | −125.8 | −123.7 | 0.32 |
| FOXA1 SRX5203307 | MCF-7 Breast | 163 / 18754 (0.9%) | 6987 / 187540 (3.7%) | −125.5 | −123.4 | 0.23 |
| AR SRX9109113 | MDA-MB-453 Breast | 942 / 18754 (5.0%) | 18747 / 187540 (10.0%) | −125.5 | −123.4 | 0.50 |
| FOXA1 SRX3923519 | MCF-7 Breast | 326 / 18754 (1.7%) | 9785 / 187540 (5.2%) | −124.9 | −122.8 | 0.33 |
| ARID5B SRX10475139 | Hep G2 Liver | 559 / 18754 (3.0%) | 13355 / 187540 (7.1%) | −124.6 | −122.5 | 0.42 |
| JUNB SRX8488073 | SUM 229PE Breast | 934 / 18754 (5.0%) | 18596 / 187540 (9.9%) | −124.5 | −122.4 | 0.50 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 361 / 18754 (1.9%) | 10317 / 187540 (5.5%) | −124.0 | −121.9 | 0.35 |
| EP300 SRX1012648 | MCF-7 Breast | 263 / 18754 (1.4%) | 8713 / 187540 (4.6%) | −123.9 | −121.8 | 0.30 |
| PGR SRX1012655 | MCF-7 Breast | 345 / 18754 (1.8%) | 10056 / 187540 (5.4%) | −123.9 | −121.8 | 0.34 |
| AHR SRX20282969 | MCF-7 Breast | 248 / 18754 (1.3%) | 8450 / 187540 (4.5%) | −123.8 | −121.7 | 0.29 |
| CDK9 SRX7366781 | MCF-7 Breast | 222 / 18754 (1.2%) | 170 / 187540 (0.1%) | −123.5 | −121.4 | 13.06 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 351 / 18754 (1.9%) | 10137 / 187540 (5.4%) | −123.4 | −121.3 | 0.35 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 667 / 18754 (3.6%) | 14842 / 187540 (7.9%) | −123.0 | −120.9 | 0.45 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 310 / 18754 (1.7%) | 9442 / 187540 (5.0%) | −122.4 | −120.3 | 0.33 |
| FOXA1 SRX5203294 | MCF-7 Breast | 163 / 18754 (0.9%) | 6892 / 187540 (3.7%) | −122.4 | −120.3 | 0.24 |
| LARP7 SRX2198835 | HeLa Uterus | 2113 / 18754 (11.3%) | 11937 / 187540 (6.4%) | −122.3 | −120.2 | 1.77 |
| SMARCA4 SRX5212362 | Mel270 Others | 869 / 18754 (4.6%) | 17603 / 187540 (9.4%) | −122.0 | −119.9 | 0.49 |
| FOXA1 SRX1787652 | MCF-7 Breast | 339 / 18754 (1.8%) | 9890 / 187540 (5.3%) | −121.8 | −119.7 | 0.34 |
| FOS SRX4192879 | MCF 10A Breast | 611 / 18754 (3.3%) | 13984 / 187540 (7.5%) | −121.6 | −119.5 | 0.44 |
| ESR1 SRX1995230 | MCF-7 Breast | 445 / 18754 (2.4%) | 11532 / 187540 (6.1%) | −121.6 | −119.5 | 0.39 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 1580 / 18754 (8.4%) | 26771 / 187540 (14.3%) | −121.4 | −119.3 | 0.59 |
| ESR1 SRX1995229 | MCF-7 Breast | 520 / 18754 (2.8%) | 12653 / 187540 (6.7%) | −121.4 | −119.3 | 0.41 |
| ESR1 SRX4451212 | MCF-7 Breast | 507 / 18754 (2.7%) | 12450 / 187540 (6.6%) | −121.2 | −119.1 | 0.41 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 548 / 18754 (2.9%) | 13053 / 187540 (7.0%) | −121.1 | −119.0 | 0.42 |
| GATAD2A SRX2636506 | Hep G2 Liver | 658 / 18754 (3.5%) | 14633 / 187540 (7.8%) | −121.0 | −119.0 | 0.45 |
| NR3C1 SRX19024866 | MCF-7 Breast | 201 / 18754 (1.1%) | 7536 / 187540 (4.0%) | −120.9 | −118.9 | 0.27 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 474 / 18754 (2.5%) | 1131 / 187540 (0.6%) | −120.4 | −118.3 | 4.19 |
| KAT6A SRX20971022 | Fibroblasts Others | 198 / 18754 (1.1%) | 123 / 187540 (0.1%) | −120.2 | −118.1 | 16.10 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 385 / 18754 (2.1%) | 10547 / 187540 (5.6%) | −120.0 | −117.9 | 0.37 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 967 / 18754 (5.2%) | 18824 / 187540 (10.0%) | −119.8 | −117.8 | 0.51 |
| FOXA2 SRX10475773 | Hep G2 Liver | 629 / 18754 (3.4%) | 14170 / 187540 (7.6%) | −119.8 | −117.8 | 0.44 |
| ESR1 SRX176856 | MCF-7 Breast | 196 / 18754 (1.0%) | 7408 / 187540 (4.0%) | −119.6 | −117.6 | 0.26 |
| GATA3 SRX5457550 | MCF-7 Breast | 601 / 18754 (3.2%) | 13753 / 187540 (7.3%) | −119.4 | −117.3 | 0.44 |
| ESR1 SRX2513521 | MCF-7 Breast | 268 / 18754 (1.4%) | 8643 / 187540 (4.6%) | −119.4 | −117.3 | 0.31 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 458 / 18754 (2.4%) | 11644 / 187540 (6.2%) | −119.3 | −117.3 | 0.39 |
| SSRP1 SRX3436566 | HT-1080 Bone | 295 / 18754 (1.6%) | 405 / 187540 (0.2%) | −119.2 | −117.1 | 7.28 |
| JUNB SRX10119386 | MCF 10A Breast | 495 / 18754 (2.6%) | 12186 / 187540 (6.5%) | −119.0 | −116.9 | 0.41 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 698 / 18754 (3.7%) | 2308 / 187540 (1.2%) | −118.9 | −116.8 | 3.02 |
| ESR1 SRX3110723 | MCF-7 Breast | 307 / 18754 (1.6%) | 9269 / 187540 (4.9%) | −118.9 | −116.8 | 0.33 |
| ESR1 SRX20282966 | MCF-7 Breast | 204 / 18754 (1.1%) | 7520 / 187540 (4.0%) | −118.8 | −116.7 | 0.27 |
| ESR1 SRX1012630 | MCF-7 Breast | 221 / 18754 (1.2%) | 7809 / 187540 (4.2%) | −118.4 | −116.3 | 0.28 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 506 / 18754 (2.7%) | 12322 / 187540 (6.6%) | −118.3 | −116.3 | 0.41 |
| ESR1 SRX7427512 | MCF-7 Breast | 526 / 18754 (2.8%) | 12614 / 187540 (6.7%) | −118.2 | −116.2 | 0.42 |
| JUN SRX17561461 | LPS141 Adipocyte | 757 / 18754 (4.0%) | 15903 / 187540 (8.5%) | −118.2 | −116.1 | 0.48 |
| FOXA1 SRX1447317 | MCF-7 Breast | 360 / 18754 (1.9%) | 10090 / 187540 (5.4%) | −118.2 | −116.1 | 0.36 |
| ESR1 SRX1012633 | MCF-7 Breast | 292 / 18754 (1.6%) | 8995 / 187540 (4.8%) | −118.0 | −116.0 | 0.32 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 374 / 18754 (2.0%) | 10295 / 187540 (5.5%) | −117.8 | −115.7 | 0.36 |
| Epitope tags SRX5877914 | U2OS Bone | 2557 / 18754 (13.6%) | 38288 / 187540 (20.4%) | −117.7 | −115.7 | 0.67 |
| FOXA1 SRX3931033 | MCF-7 Breast | 348 / 18754 (1.9%) | 9876 / 187540 (5.3%) | −117.4 | −115.4 | 0.35 |
| 5-mC SRX882970 | LNCAP Prostate | 2730 / 18754 (14.6%) | 16960 / 187540 (9.0%) | −117.2 | −115.2 | 1.61 |
| ING5 SRX286202 | RKO Digestive tract | 1244 / 18754 (6.6%) | 5767 / 187540 (3.1%) | −117.1 | −115.1 | 2.16 |
| ESR1 SRX10365534 | MCF-7 Breast | 176 / 18754 (0.9%) | 6962 / 187540 (3.7%) | −117.0 | −114.9 | 0.25 |
| ARID1A SRX5089385 | MCF-7 Breast | 413 / 18754 (2.2%) | 10867 / 187540 (5.8%) | −116.9 | −114.8 | 0.38 |
| FOXA1 SRX5323845 | MCF-7 Breast | 213 / 18754 (1.1%) | 7616 / 187540 (4.1%) | −116.8 | −114.7 | 0.28 |
| SMARCA4 SRX5212357 | Mel270 Others | 758 / 18754 (4.0%) | 15855 / 187540 (8.5%) | −116.7 | −114.7 | 0.48 |
| FOXA1 SRX5323846 | MCF-7 Breast | 220 / 18754 (1.2%) | 7735 / 187540 (4.1%) | −116.7 | −114.7 | 0.28 |
| ESR1 SRX20282967 | MCF-7 Breast | 177 / 18754 (0.9%) | 6967 / 187540 (3.7%) | −116.6 | −114.6 | 0.25 |
| ARID5B SRX10475138 | Hep G2 Liver | 854 / 18754 (4.6%) | 17144 / 187540 (9.1%) | −116.3 | −114.3 | 0.50 |
| CEBPB SRX2194250 | SUM 159PT Breast | 637 / 18754 (3.4%) | 14139 / 187540 (7.5%) | −116.2 | −114.2 | 0.45 |
| DTL SRX4107934 | U2OS Bone | 1132 / 18754 (6.0%) | 5040 / 187540 (2.7%) | −116.0 | −114.0 | 2.25 |
| FOXA1 SRX3931032 | MCF-7 Breast | 323 / 18754 (1.7%) | 9421 / 187540 (5.0%) | −115.9 | −113.9 | 0.34 |
| NFYB SRX16608147 | HeLa Uterus | 238 / 18754 (1.3%) | 240 / 187540 (0.1%) | −115.8 | −113.7 | 9.92 |
| ESR1 SRX5534831 | MCF-7 Breast | 429 / 18754 (2.3%) | 11060 / 187540 (5.9%) | −115.5 | −113.5 | 0.39 |
| NANOG SRX10448024 | hESC H1 Pluripotent stem cell | 1678 / 18754 (8.9%) | 27638 / 187540 (14.7%) | −114.9 | −112.9 | 0.61 |
| SMARCA4 SRX5212366 | Mel270 Others | 713 / 18754 (3.8%) | 15145 / 187540 (8.1%) | −114.8 | −112.8 | 0.47 |
| 5-mC SRX882968 | LNCAP Prostate | 2700 / 18754 (14.4%) | 16816 / 187540 (9.0%) | −114.7 | −112.7 | 1.61 |
| VGLL1 SRX24602130 | BT-20 Breast | 578 / 18754 (3.1%) | 13230 / 187540 (7.1%) | −114.7 | −112.6 | 0.44 |
| NANOG SRX10445309 | Neural crest cells Neural | 306 / 18754 (1.6%) | 9104 / 187540 (4.9%) | −114.6 | −112.6 | 0.34 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 1071 / 18754 (5.7%) | 19940 / 187540 (10.6%) | −114.3 | −112.3 | 0.54 |
| ESR1 SRX5323874 | MCF-7 Breast | 332 / 18754 (1.8%) | 9508 / 187540 (5.1%) | −114.2 | −112.2 | 0.35 |
| FOXA1 SRX3923510 | MCF-7 Breast | 224 / 18754 (1.2%) | 7719 / 187540 (4.1%) | −114.2 | −112.2 | 0.29 |
| TCF12 SRX190356 | SK-N-SH Neural | 1345 / 18754 (7.2%) | 23435 / 187540 (12.5%) | −113.8 | −111.8 | 0.57 |
| TRPS1 SRX3401273 | MCF-7 Breast | 201 / 18754 (1.1%) | 7310 / 187540 (3.9%) | −113.8 | −111.8 | 0.27 |
| EP300 SRX1012644 | MCF-7 Breast | 268 / 18754 (1.4%) | 8446 / 187540 (4.5%) | −113.7 | −111.7 | 0.32 |
| ESR1 SRX2513518 | MCF-7 Breast | 282 / 18754 (1.5%) | 8675 / 187540 (4.6%) | −113.7 | −111.7 | 0.33 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 467 / 18754 (2.5%) | 11558 / 187540 (6.2%) | −113.5 | −111.5 | 0.40 |
| ESR1 SRX792933 | LY2 Breast | 458 / 18754 (2.4%) | 11421 / 187540 (6.1%) | −113.5 | −111.5 | 0.40 |
| GATAD2A SRX2636507 | Hep G2 Liver | 581 / 18754 (3.1%) | 13219 / 187540 (7.0%) | −113.3 | −111.3 | 0.44 |
| FOXA1 SRX1161203 | T-47D Breast | 406 / 18754 (2.2%) | 10619 / 187540 (5.7%) | −113.2 | −111.2 | 0.38 |
| ESR1 SRX1012625 | MCF-7 Breast | 306 / 18754 (1.6%) | 9044 / 187540 (4.8%) | −113.0 | −111.0 | 0.34 |
| ESR1 SRX2513519 | MCF-7 Breast | 312 / 18754 (1.7%) | 9139 / 187540 (4.9%) | −113.0 | −111.0 | 0.34 |
| FOXA1 SRX3923511 | MCF-7 Breast | 229 / 18754 (1.2%) | 7764 / 187540 (4.1%) | −112.9 | −110.9 | 0.29 |
| ESR1 SRX1012628 | MCF-7 Breast | 298 / 18754 (1.6%) | 8909 / 187540 (4.8%) | −112.9 | −110.9 | 0.33 |
| CBX3 SRX055346 | HCT 116 Digestive tract | 248 / 18754 (1.3%) | 282 / 187540 (0.2%) | −112.8 | −110.8 | 8.79 |
| ARID1A SRX5089382 | MCF-7 Breast | 398 / 18754 (2.1%) | 10484 / 187540 (5.6%) | −112.7 | −110.7 | 0.38 |
| ESR1 SRX4451214 | MCF-7 Breast | 489 / 18754 (2.6%) | 11848 / 187540 (6.3%) | −112.7 | −110.7 | 0.41 |
| FOXA1 SRX3931056 | MCF-7 Breast | 334 / 18754 (1.8%) | 9483 / 187540 (5.1%) | −112.6 | −110.7 | 0.35 |
| TP53 SRX396254 | Fibroblasts Others | 805 / 18754 (4.3%) | 3023 / 187540 (1.6%) | −112.6 | −110.7 | 2.66 |
| FOXA3 SRX2630190 | Hep G2 Liver | 460 / 18754 (2.5%) | 11414 / 187540 (6.1%) | −112.5 | −110.6 | 0.40 |
| TP53 SRX19538272 | U2OS Bone | 497 / 18754 (2.7%) | 1317 / 187540 (0.7%) | −112.5 | −110.5 | 3.77 |
| ESR1 SRX3110720 | MCF-7 Breast | 248 / 18754 (1.3%) | 8072 / 187540 (4.3%) | −112.4 | −110.4 | 0.31 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 1546 / 18754 (8.2%) | 25872 / 187540 (13.8%) | −112.3 | −110.4 | 0.60 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 222 / 18754 (1.2%) | 7618 / 187540 (4.1%) | −112.2 | −110.2 | 0.29 |
| NCOA3 SRX4663589 | MCF-7 Breast | 177 / 18754 (0.9%) | 6819 / 187540 (3.6%) | −111.8 | −109.9 | 0.26 |
| SSRP1 SRX3436563 | HT-1080 Bone | 823 / 18754 (4.4%) | 3146 / 187540 (1.7%) | −111.8 | −109.8 | 2.62 |
| NR3C1 SRX19024870 | MCF-7 Breast | 207 / 18754 (1.1%) | 7345 / 187540 (3.9%) | −111.7 | −109.7 | 0.28 |
| ZEB1 SRX13298925 | MCF-7 Breast | 354 / 18754 (1.9%) | 9756 / 187540 (5.2%) | −111.6 | −109.6 | 0.36 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 461 / 18754 (2.5%) | 11384 / 187540 (6.1%) | −111.3 | −109.3 | 0.40 |
| ARID1A SRX5089388 | MCF-7 Breast | 297 / 18754 (1.6%) | 8837 / 187540 (4.7%) | −111.3 | −109.3 | 0.34 |
| EP300 SRX176883 | MCF-7 Breast | 276 / 18754 (1.5%) | 8492 / 187540 (4.5%) | −111.2 | −109.2 | 0.33 |
| ESR1 SRX5534832 | MCF-7 Breast | 501 / 18754 (2.7%) | 11960 / 187540 (6.4%) | −111.0 | −109.0 | 0.42 |
| FOXA1 SRX3923513 | MCF-7 Breast | 185 / 18754 (1.0%) | 6927 / 187540 (3.7%) | −110.8 | −108.8 | 0.27 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 721 / 18754 (3.8%) | 15083 / 187540 (8.0%) | −110.8 | −108.8 | 0.48 |
| NR3C1 SRX1161167 | MCF-7 Breast | 165 / 18754 (0.9%) | 6565 / 187540 (3.5%) | −110.7 | −108.8 | 0.25 |
| VGLL1 SRX18013277 | FULVR Breast | 261 / 18754 (1.4%) | 8231 / 187540 (4.4%) | −110.7 | −108.7 | 0.32 |
| ESR1 SRX1161186 | ZR-75-1 Breast | 199 / 18754 (1.1%) | 7168 / 187540 (3.8%) | −110.7 | −108.7 | 0.28 |
| 5-hmC SRX19636323 | HMLE Breast | 1353 / 18754 (7.2%) | 6674 / 187540 (3.6%) | −110.6 | −108.6 | 2.03 |
| ESR1 SRX1469950 | MCF-7 Breast | 224 / 18754 (1.2%) | 7601 / 187540 (4.1%) | −110.6 | −108.6 | 0.29 |
| FOXA1 SRX8537737 | MCF-7 Breast | 229 / 18754 (1.2%) | 7662 / 187540 (4.1%) | −109.9 | −107.9 | 0.30 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 392 / 18754 (2.1%) | 849 / 187540 (0.5%) | −109.7 | −107.8 | 4.62 |
| TFAP2C SRX018833 | MCF-7 Breast | 499 / 18754 (2.7%) | 11880 / 187540 (6.3%) | −109.7 | −107.8 | 0.42 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 1152 / 18754 (6.1%) | 20762 / 187540 (11.1%) | −109.6 | −107.7 | 0.55 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 912 / 18754 (4.9%) | 17623 / 187540 (9.4%) | −109.6 | −107.7 | 0.52 |
| EP300 SRX150579 | HeLa Uterus | 386 / 18754 (2.1%) | 10183 / 187540 (5.4%) | −109.6 | −107.7 | 0.38 |
| FOXA1 SRX8537736 | MCF-7 Breast | 214 / 18754 (1.1%) | 7395 / 187540 (3.9%) | −109.6 | −107.6 | 0.29 |
| AHR SRX2378695 | MCF-7 Breast | 258 / 18754 (1.4%) | 8141 / 187540 (4.3%) | −109.6 | −107.6 | 0.32 |
| SMARCA4 SRX5212371 | Mel270 Others | 758 / 18754 (4.0%) | 15534 / 187540 (8.3%) | −109.5 | −107.6 | 0.49 |
| FOXA1 SRX15430999 | T-47D Breast | 613 / 18754 (3.3%) | 13504 / 187540 (7.2%) | −109.2 | −107.3 | 0.45 |
| FOXA1 SRX3923508 | MCF-7 Breast | 196 / 18754 (1.0%) | 7068 / 187540 (3.8%) | −109.1 | −107.2 | 0.28 |
| CBX3 SRX6712570 | MCF-7 Breast | 451 / 18754 (2.4%) | 11147 / 187540 (5.9%) | −109.1 | −107.1 | 0.40 |
| FOXA1 SRX1787654 | MCF-7 Breast | 228 / 18754 (1.2%) | 7617 / 187540 (4.1%) | −109.1 | −107.1 | 0.30 |
| STAT3 SRX2020842 | HCC70 Breast | 927 / 18754 (4.9%) | 17793 / 187540 (9.5%) | −109.0 | −107.1 | 0.52 |
| EP300 SRX1012643 | MCF-7 Breast | 228 / 18754 (1.2%) | 7614 / 187540 (4.1%) | −108.9 | −107.0 | 0.30 |
| TFAP2C SRX128099 | MCF-7 Breast | 500 / 18754 (2.7%) | 11859 / 187540 (6.3%) | −108.8 | −106.8 | 0.42 |
| ESR1 SRX3123823 | MCF-7 Breast | 215 / 18754 (1.1%) | 7375 / 187540 (3.9%) | −108.4 | −106.5 | 0.29 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 529 / 18754 (2.8%) | 12260 / 187540 (6.5%) | −108.2 | −106.3 | 0.43 |
| ESR1 SRX5323876 | MCF-7 Breast | 314 / 18754 (1.7%) | 9005 / 187540 (4.8%) | −108.2 | −106.3 | 0.35 |
| EP300 SRX100544 | Hep G2 Liver | 430 / 18754 (2.3%) | 10797 / 187540 (5.8%) | −108.2 | −106.2 | 0.40 |
| TEAD3 SRX2636153 | Hep G2 Liver | 1222 / 18754 (6.5%) | 21557 / 187540 (11.5%) | −107.6 | −105.7 | 0.57 |
| FOXA1 SRX3923509 | MCF-7 Breast | 183 / 18754 (1.0%) | 6786 / 187540 (3.6%) | −107.5 | −105.6 | 0.27 |
| ESR1 SRX9719167 | MCF-7 Breast | 268 / 18754 (1.4%) | 8231 / 187540 (4.4%) | −107.5 | −105.5 | 0.33 |
| SOX5 SRX2636544 | Hep G2 Liver | 555 / 18754 (3.0%) | 12601 / 187540 (6.7%) | −107.4 | −105.4 | 0.44 |
| SKP2 SRX4107930 | HCT 116 Digestive tract | 1112 / 18754 (5.9%) | 5092 / 187540 (2.7%) | −107.3 | −105.4 | 2.18 |
| ESR1 SRX8537719 | SUM 44PE Breast | 356 / 18754 (1.9%) | 9628 / 187540 (5.1%) | −107.2 | −105.3 | 0.37 |
| FOXA1 SRX1161172 | MCF-7 Breast | 557 / 18754 (3.0%) | 12616 / 187540 (6.7%) | −107.1 | −105.1 | 0.44 |
| ESR1 SRX2922232 | SUM 44PE Breast | 255 / 18754 (1.4%) | 7999 / 187540 (4.3%) | −106.9 | −105.0 | 0.32 |
| CEBPB SRX2194249 | SUM 159PT Breast | 550 / 18754 (2.9%) | 12507 / 187540 (6.7%) | −106.9 | −104.9 | 0.44 |
| GATA3 SRX190194 | SK-N-SH Neural | 1211 / 18754 (6.5%) | 21379 / 187540 (11.4%) | −106.8 | −104.9 | 0.57 |
| ESR1 SRX8537718 | SUM 44PE Breast | 344 / 18754 (1.8%) | 9424 / 187540 (5.0%) | −106.8 | −104.9 | 0.37 |
| HNF4A SRX10475578 | Hep G2 Liver | 597 / 18754 (3.2%) | 13177 / 187540 (7.0%) | −106.8 | −104.9 | 0.45 |
| KDM6A SRX15826236 | MCF-7 Breast | 206 / 18754 (1.1%) | 7161 / 187540 (3.8%) | −106.7 | −104.8 | 0.29 |
| NANOG SRX017277 | hESC H1 Pluripotent stem cell | 240 / 18754 (1.3%) | 7741 / 187540 (4.1%) | −106.6 | −104.7 | 0.31 |
| FOXA2 SRX11650945 | hESC derived pancreatic cells Pluripotent stem cell | 360 / 18754 (1.9%) | 9663 / 187540 (5.2%) | −106.5 | −104.5 | 0.37 |
| ESR1 SRX3123830 | MCF-7 Breast | 182 / 18754 (1.0%) | 6723 / 187540 (3.6%) | −106.1 | −104.2 | 0.27 |
| STAT3 SRX150630 | MCF 10A Breast | 530 / 18754 (2.8%) | 12185 / 187540 (6.5%) | −106.0 | −104.1 | 0.43 |
| AR SRX11149848 | MDA-MB-453 Breast | 376 / 18754 (2.0%) | 9889 / 187540 (5.3%) | −105.9 | −104.0 | 0.38 |
| AR SRX15946405 | MDA-MB-453 Breast | 376 / 18754 (2.0%) | 9889 / 187540 (5.3%) | −105.9 | −104.0 | 0.38 |
| NR3C1 SRX1161181 | ZR-75-1 Breast | 186 / 18754 (1.0%) | 6785 / 187540 (3.6%) | −105.8 | −103.9 | 0.27 |
| JUN SRX4192884 | MCF 10A Breast | 492 / 18754 (2.6%) | 11613 / 187540 (6.2%) | −105.6 | −103.7 | 0.42 |
| KMT2C SRX1787675 | MCF-7 Breast | 495 / 18754 (2.6%) | 11647 / 187540 (6.2%) | −105.3 | −103.4 | 0.43 |
| FOXA1 SRX5323829 | T-47D Breast | 339 / 18754 (1.8%) | 9292 / 187540 (5.0%) | −105.3 | −103.4 | 0.36 |
| ESR1 SRX5089450 | MCF-7 Breast | 323 / 18754 (1.7%) | 9026 / 187540 (4.8%) | −104.9 | −103.0 | 0.36 |
| RXRB SRX2636027 | Hep G2 Liver | 600 / 18754 (3.2%) | 13133 / 187540 (7.0%) | −104.8 | −102.9 | 0.46 |
| FOS SRX3322637 | MCF-7 Breast | 325 / 18754 (1.7%) | 9050 / 187540 (4.8%) | −104.7 | −102.7 | 0.36 |
| TET2 SRX8617001 | MCF-7 Breast | 391 / 18754 (2.1%) | 10063 / 187540 (5.4%) | −104.5 | −102.6 | 0.39 |
| ESR1 SRX5089447 | MCF-7 Breast | 283 / 18754 (1.5%) | 8371 / 187540 (4.5%) | −104.5 | −102.5 | 0.34 |
| ESR1 SRX1012631 | MCF-7 Breast | 275 / 18754 (1.5%) | 8235 / 187540 (4.4%) | −104.3 | −102.4 | 0.33 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1256 / 18754 (6.7%) | 6152 / 187540 (3.3%) | −104.3 | −102.4 | 2.04 |
| FOXA1 SRX1961158 | T-47D Breast | 561 / 18754 (3.0%) | 12555 / 187540 (6.7%) | −104.3 | −102.4 | 0.45 |
| STAT3 SRX150479 | MCF 10A Breast | 539 / 18754 (2.9%) | 12242 / 187540 (6.5%) | −104.2 | −102.3 | 0.44 |
| FOXA1 SRX3931031 | MCF-7 Breast | 289 / 18754 (1.5%) | 8462 / 187540 (4.5%) | −104.2 | −102.3 | 0.34 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 1022 / 18754 (5.4%) | 18813 / 187540 (10.0%) | −104.2 | −102.3 | 0.54 |
| FOXA2 SRX10475774 | Hep G2 Liver | 268 / 18754 (1.4%) | 8113 / 187540 (4.3%) | −104.0 | −102.1 | 0.33 |
| NR3C1 SRX19024880 | MCF-7 Breast | 172 / 18754 (0.9%) | 6477 / 187540 (3.5%) | −104.0 | −102.1 | 0.27 |
| 5-mC SRX882965 | LNCAP Prostate | 2181 / 18754 (11.6%) | 13090 / 187540 (7.0%) | −103.9 | −102.0 | 1.67 |
| JUNB SRX8488074 | SUM 229PE Breast | 741 / 18754 (4.0%) | 15049 / 187540 (8.0%) | −103.8 | −101.9 | 0.49 |
| Epitope tags SRX5877913 | U2OS Bone | 2580 / 18754 (13.8%) | 37700 / 187540 (20.1%) | −103.8 | −101.9 | 0.68 |
| Epitope tags SRX8080559 | Mammary gland adenocarcinoma Breast | 266 / 18754 (1.4%) | 8059 / 187540 (4.3%) | −103.5 | −101.6 | 0.33 |
| ESR1 SRX5287697 | MCF-7 Breast | 233 / 18754 (1.2%) | 7509 / 187540 (4.0%) | −103.3 | −101.4 | 0.31 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 800 / 18754 (4.3%) | 15825 / 187540 (8.4%) | −103.3 | −101.4 | 0.51 |
| 5-hmC SRX19636322 | HMLE Breast | 1618 / 18754 (8.6%) | 8797 / 187540 (4.7%) | −103.2 | −101.3 | 1.84 |
| NR3C1 SRX8520802 | HCC1187 Breast | 439 / 18754 (2.3%) | 10734 / 187540 (5.7%) | −103.2 | −101.3 | 0.41 |
| ARID1A SRX5089391 | MCF-7 Breast | 345 / 18754 (1.8%) | 9306 / 187540 (5.0%) | −103.1 | −101.2 | 0.37 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 188 / 18754 (1.0%) | 6729 / 187540 (3.6%) | −103.0 | −101.1 | 0.28 |
| FOXA1 SRX6878603 | LNCAP Prostate | 618 / 18754 (3.3%) | 13310 / 187540 (7.1%) | −103.0 | −101.1 | 0.46 |
| FOS SRX3322636 | MCF-7 Breast | 396 / 18754 (2.1%) | 10083 / 187540 (5.4%) | −102.9 | −101.1 | 0.39 |
| ZEB1 SRX13298923 | MCF-7 Breast | 265 / 18754 (1.4%) | 8016 / 187540 (4.3%) | −102.7 | −100.9 | 0.33 |
| FOXA1 SRX9550926 | Prostate cancer Prostate | 651 / 18754 (3.5%) | 13756 / 187540 (7.3%) | −102.6 | −100.8 | 0.47 |
| ZEB1 SRX13298924 | MCF-7 Breast | 299 / 18754 (1.6%) | 8563 / 187540 (4.6%) | −102.6 | −100.7 | 0.35 |
| FOXA1 SRX10024494 | MCF-7 Breast | 123 / 18754 (0.7%) | 5522 / 187540 (2.9%) | −102.5 | −100.6 | 0.22 |
| JUNB SRX10119384 | MCF 10A Breast | 376 / 18754 (2.0%) | 9756 / 187540 (5.2%) | −102.4 | −100.5 | 0.39 |
| FOXA1 SRX5203311 | MCF-7 Breast | 118 / 18754 (0.6%) | 5426 / 187540 (2.9%) | −102.4 | −100.5 | 0.22 |
| FOXA1 SRX1961157 | T-47D Breast | 615 / 18754 (3.3%) | 13242 / 187540 (7.1%) | −102.3 | −100.5 | 0.46 |
| STAT3 SRX150536 | MCF 10A Breast | 637 / 18754 (3.4%) | 13542 / 187540 (7.2%) | −102.2 | −100.3 | 0.47 |
| FOXA1 SRX5323844 | MCF-7 Breast | 189 / 18754 (1.0%) | 6714 / 187540 (3.6%) | −102.1 | −100.3 | 0.28 |
| JUNB SRX4192882 | MCF 10A Breast | 481 / 18754 (2.6%) | 11304 / 187540 (6.0%) | −101.9 | −100.1 | 0.43 |
| WWTR1 SRX10119367 | MCF 10A Breast | 659 / 18754 (3.5%) | 13830 / 187540 (7.4%) | −101.8 | −99.9 | 0.48 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 549 / 18754 (2.9%) | 12282 / 187540 (6.5%) | −101.7 | −99.8 | 0.45 |
| FOXA1 SRX1161207 | T-47D Breast | 266 / 18754 (1.4%) | 7990 / 187540 (4.3%) | −101.5 | −99.7 | 0.33 |
| SKP2 SRX4107932 | HCT 116 Digestive tract | 1188 / 18754 (6.3%) | 5752 / 187540 (3.1%) | −101.2 | −99.3 | 2.07 |
| ESR1 SRX5323875 | MCF-7 Breast | 238 / 18754 (1.3%) | 7518 / 187540 (4.0%) | −101.1 | −99.3 | 0.32 |
| FOXP1 SRX5457476 | Hep G2 Liver | 228 / 18754 (1.2%) | 7346 / 187540 (3.9%) | −101.0 | −99.1 | 0.31 |
| ESR1 SRX176858 | MCF-7 Breast | 224 / 18754 (1.2%) | 7275 / 187540 (3.9%) | −101.0 | −99.1 | 0.31 |
| DNA-RNA hybrid SRX20083261 | SH-SY5Y Neural | 518 / 18754 (2.8%) | 1551 / 187540 (0.8%) | −100.9 | −99.1 | 3.34 |
| FOXA1 SRX3931073 | MCF-7 Breast | 362 / 18754 (1.9%) | 9483 / 187540 (5.1%) | −100.9 | −99.1 | 0.38 |
| AHDC1 SRX10477202 | Hep G2 Liver | 362 / 18754 (1.9%) | 9486 / 187540 (5.1%) | −100.9 | −99.1 | 0.38 |
| ESR1 SRX1585242 | MCF-7 Breast | 242 / 18754 (1.3%) | 7569 / 187540 (4.0%) | −100.8 | −98.9 | 0.32 |
| FOXA2 SRX11650947 | hESC derived pancreatic cells Pluripotent stem cell | 399 / 18754 (2.1%) | 10044 / 187540 (5.4%) | −100.8 | −98.9 | 0.40 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 1467 / 18754 (7.8%) | 24254 / 187540 (12.9%) | −100.6 | −98.7 | 0.60 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 1025 / 18754 (5.5%) | 4654 / 187540 (2.5%) | −100.5 | −98.7 | 2.20 |
| FOXP1 SRX3230385 | Hep G2 Liver | 230 / 18754 (1.2%) | 7355 / 187540 (3.9%) | −100.3 | −98.4 | 0.31 |
| FOXA1 SRX17794420 | 22Rv1 Prostate | 402 / 18754 (2.1%) | 10063 / 187540 (5.4%) | −100.2 | −98.3 | 0.40 |
| FOXA2 SRX11650946 | hESC derived pancreatic cells Pluripotent stem cell | 315 / 18754 (1.7%) | 8721 / 187540 (4.7%) | −100.1 | −98.2 | 0.36 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 566 / 18754 (3.0%) | 12449 / 187540 (6.6%) | −100.0 | −98.2 | 0.45 |
| FOXA2 SRX11650943 | hESC derived pancreatic cells Pluripotent stem cell | 372 / 18754 (2.0%) | 9603 / 187540 (5.1%) | −100.0 | −98.1 | 0.39 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 519 / 18754 (2.8%) | 11768 / 187540 (6.3%) | −99.8 | −97.9 | 0.44 |
| FOXA3 SRX2630189 | Hep G2 Liver | 468 / 18754 (2.5%) | 11019 / 187540 (5.9%) | −99.5 | −97.7 | 0.42 |
| JUN SRX6582171 | GM07492 Others | 1045 / 18754 (5.6%) | 18878 / 187540 (10.1%) | −99.5 | −97.6 | 0.55 |
| FOXA1 SRX1161205 | T-47D Breast | 337 / 18754 (1.8%) | 9044 / 187540 (4.8%) | −99.4 | −97.6 | 0.37 |
| SP1 SRX5457499 | Liver Liver | 937 / 18754 (5.0%) | 17467 / 187540 (9.3%) | −99.4 | −97.6 | 0.54 |
| TET2 SRX8617003 | MCF-7 Breast | 217 / 18754 (1.2%) | 7104 / 187540 (3.8%) | −99.4 | −97.6 | 0.31 |
| JUNB SRX10119383 | MCF 10A Breast | 426 / 18754 (2.3%) | 10386 / 187540 (5.5%) | −99.2 | −97.4 | 0.41 |
| ESR1 SRX2922231 | SUM 44PE Breast | 358 / 18754 (1.9%) | 9353 / 187540 (5.0%) | −99.0 | −97.2 | 0.38 |
| ESR1 SRX968963 | MCF-7 Breast | 267 / 18754 (1.4%) | 7917 / 187540 (4.2%) | −99.0 | −97.2 | 0.34 |
| NFIL3 SRX2630334 | Hep G2 Liver | 477 / 18754 (2.5%) | 11128 / 187540 (5.9%) | −99.0 | −97.2 | 0.43 |
| EP300 SRX2671820 | iPS cells Pluripotent stem cell | 169 / 18754 (0.9%) | 6254 / 187540 (3.3%) | −98.8 | −96.9 | 0.27 |
| JUNB SRX8488089 | SUM 229PE Breast | 593 / 18754 (3.2%) | 12774 / 187540 (6.8%) | −98.7 | −96.9 | 0.46 |
| ESR1 SRX7624162 | T-47D Breast | 353 / 18754 (1.9%) | 9260 / 187540 (4.9%) | −98.6 | −96.8 | 0.38 |
| JUND SRX150408 | HeLa Uterus | 525 / 18754 (2.8%) | 11801 / 187540 (6.3%) | −98.5 | −96.7 | 0.44 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 532 / 18754 (2.8%) | 11900 / 187540 (6.3%) | −98.5 | −96.7 | 0.45 |
| SSRP1 SRX3436564 | HT-1080 Bone | 470 / 18754 (2.5%) | 1329 / 187540 (0.7%) | −98.5 | −96.6 | 3.54 |
| HNF4A SRX10475577 | Hep G2 Liver | 376 / 18754 (2.0%) | 9602 / 187540 (5.1%) | −98.4 | −96.6 | 0.39 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 1461 / 18754 (7.8%) | 24062 / 187540 (12.8%) | −98.4 | −96.5 | 0.61 |
| ESR1 SRX3080214 | MCF-7 Breast | 169 / 18754 (0.9%) | 6237 / 187540 (3.3%) | −98.2 | −96.4 | 0.27 |
| FOXA1 SRX5323850 | MCF-7 Breast | 178 / 18754 (0.9%) | 6392 / 187540 (3.4%) | −98.2 | −96.3 | 0.28 |
| ESR1 SRX20282945 | MCF-7 Breast | 178 / 18754 (0.9%) | 6394 / 187540 (3.4%) | −98.2 | −96.3 | 0.28 |
| FOXA1 SRX10024492 | MCF-7 Breast | 147 / 18754 (0.8%) | 5838 / 187540 (3.1%) | −98.1 | −96.3 | 0.25 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 554 / 18754 (3.0%) | 12199 / 187540 (6.5%) | −98.1 | −96.2 | 0.45 |
| FOSL2 SRX10475315 | Hep G2 Liver | 630 / 18754 (3.4%) | 13260 / 187540 (7.1%) | −97.9 | −96.1 | 0.48 |
| ESR1 SRX2881004 | MCF-7 Breast | 178 / 18754 (0.9%) | 6386 / 187540 (3.4%) | −97.9 | −96.0 | 0.28 |
| BrdU SRX3758833 | HeLa Uterus | 445 / 18754 (2.4%) | 1209 / 187540 (0.6%) | −97.8 | −96.0 | 3.68 |
| FOXA2 SRX11650941 | hESC derived pancreatic cells Pluripotent stem cell | 310 / 18754 (1.7%) | 8561 / 187540 (4.6%) | −97.8 | −95.9 | 0.36 |
| FOXA1 SRX9550898 | Prostate cancer Prostate | 420 / 18754 (2.2%) | 10237 / 187540 (5.5%) | −97.7 | −95.8 | 0.41 |
| SOX6 SRX10475370 | Hep G2 Liver | 959 / 18754 (5.1%) | 17644 / 187540 (9.4%) | −97.2 | −95.4 | 0.54 |
| ESR1 SRX3554403 | MDA-MB-134-VI Breast | 287 / 18754 (1.5%) | 8171 / 187540 (4.4%) | −97.1 | −95.3 | 0.35 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 829 / 18754 (4.4%) | 15928 / 187540 (8.5%) | −97.1 | −95.3 | 0.52 |
| CEBPB SRX3584202 | Epididymis Gonad | 543 / 18754 (2.9%) | 12000 / 187540 (6.4%) | −97.1 | −95.3 | 0.45 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 570 / 18754 (3.0%) | 12372 / 187540 (6.6%) | −96.9 | −95.0 | 0.46 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 551 / 18754 (2.9%) | 12102 / 187540 (6.5%) | −96.9 | −95.0 | 0.46 |
| RARA SRX2635936 | Hep G2 Liver | 488 / 18754 (2.6%) | 11196 / 187540 (6.0%) | −96.8 | −95.0 | 0.44 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 1055 / 18754 (5.6%) | 18862 / 187540 (10.1%) | −96.6 | −94.8 | 0.56 |
| ESR1 SRX176857 | MCF-7 Breast | 228 / 18754 (1.2%) | 7190 / 187540 (3.8%) | −96.5 | −94.7 | 0.32 |
| MAU2 SRX11120892 | MCF-7 Breast | 282 / 18754 (1.5%) | 8070 / 187540 (4.3%) | −96.5 | −94.7 | 0.35 |
| MCM2 SRX12221314 | HCT 116 Digestive tract | 365 / 18754 (1.9%) | 838 / 187540 (0.4%) | −96.5 | −94.7 | 4.36 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 1307 / 18754 (7.0%) | 22046 / 187540 (11.8%) | −96.5 | −94.7 | 0.59 |
| ZNF219 SRX3230413 | Hep G2 Liver | 942 / 18754 (5.0%) | 17384 / 187540 (9.3%) | −96.4 | −94.6 | 0.54 |
| EP300 SRX2194265 | SUM 159PT Breast | 877 / 18754 (4.7%) | 16530 / 187540 (8.8%) | −96.4 | −94.6 | 0.53 |
| ESRRA SRX1473610 | BT-474 Breast | 353 / 18754 (1.9%) | 9174 / 187540 (4.9%) | −96.4 | −94.6 | 0.38 |
Showing first 500 of 17400 rows.